MANAGING ULCERATIVE COLITIS BY INCREASING HYDROGEN PRODUCTION VIA ORAL ADMINISTRATION OF ACARBOSE

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 10, Issue 5, 2013, Pages 356-359

  Zhu, Jian Hong ^a   Zhang, De Qing ^a   Chen, Wei Chang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Acarbose; hydrogen; Ulcerative colitis

Indexed keywords

ACARBOSE; ANTIDIABETIC AGENT; HYDROGEN;

ANIMAL; ARTICLE; BACTERIUM; DRUG EFFECT; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MOUSE; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; ULCERATIVE COLITIS;

ACARBOSE; HYDROGEN; ULCERATIVE COLITIS;

ACARBOSE; ADMINISTRATION, ORAL; ANIMALS; BACTERIA; COLITIS, ULCERATIVE; GASTROINTESTINAL TRACT; HYDROGEN; HYPOGLYCEMIC AGENTS; MICE; OXIDATIVE STRESS;

EID: 84904845704     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v10i5.23     Document Type: Note

References (22)

1. .A. B. Hawthorne, G Rubin, S.(2008).Ghosh.Review article: medication non-adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapies.Alimentary Pharmacology & Therapeutics.27:1157-1166.
2. A Roessner, D Kuester, P Malfertheiner. 2008.Oxidative stress in ulcerative colitis-associated carcinogenesis. Research and Practice.204:511-524.
3. Carty E, Rampton DS. (2003). Evaluation of new therapies for inflammatory bowel disease. J Clin Pharmacol.56:351–61.
4. Chen H, Sun YP, Li Y, Liu WW, Xiang HG, Fan LY, Sun Q, Xu XY, Cai JM, Ruan CP, Su N, Yan RL, Sun XJ, Wang Q. 2010.Hydrogen-rich saline ameliorates the severity of L-arginine-induced acute pancreatitis in rats. Biochem Biophys Res Commun.393:308-313.
5. Chen X, Zuo Q, Hai Y, Sun XJ. 2011. Lactulose: An indirect antioxidant ameliorating inflammatory bowel disease by increasing hydrogen production. Medical hypotheses. 76:325-32.
6. Fries W, Comunale S. 2011.Ulcerative Colitis:Pathogenesis.Current Drug Targets. 12:1373-1382.
7. Gil V, Parsons S, Gallego D, Huizinga J, Jimenez M. (2013).Effects of hydrogen sulphide on motility patterns in the rat colon. British Journal of Pharmacology. DOI: 10.1111/bph.12100
8. Gloire G, Legrand-Poels S, Piette J. 2006.NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol.72:1493–1505.
9. Grisham MB, Granger DN. 1998.Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci.33:6S–15S.
10. Hanefeld M., Cagatay M., Petrowitsch T. (2004).Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. European Heart Journal.25: 10-16.
11. .IC Solberg, I Lygren, J Jahnsen. (2008).Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scandinavian Journal of Gastroenterology.27:1157-1166.
12. Kajiya M, Silva MJ, Sato K, Ouhara K, Kawai T. 2009.Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate. Biochem Biophys Res Commun 386:11–15.
13. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, Kitawaki J, Imai S, Nakano K, Ohta M, Adachi T, Obayashi H, Yoshikawa T. (2008).Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr. Res.28:137–143.
14. Karp SM, Koch TR. 2006.Oxidative stress and antioxidants in inflammatory bowel disease. Dis Mon.52:199–207.
15. Michael D, Levitt, M D. (1969).Production and excretion of hydrogen gas in man. New England Journal of Medicine.281:122-127.
16. Moe KT, Aulia S, Jiang F, Chua YL, Koh TH, Wong MC, Dusting GJ. 2006.Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factoralpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med.10:231–239.
17. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S.(2007).Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals.Nature Medicine.13:688 – 694.
18. Oz HS, Chen TS, McClain CJ, de Villiers WJ. 2005.Antioxidants as novel therapy in a murine model of colitis. J Nutr Biochem.16:297–304.
19. S D Ladas, A Frydas, A Papadopoulos, SA Raptis. (1992). Effects of α-glucosidase inhibitors on mouth to caecum transit time in humans. Gut.33:1246–1248.
20. S Ohta. 2012.Molecular hydrogen is a novel antioxidant to efficiently reduce oxidative stress with potential for the improvement of mitochondrial diseases. Biochimica et Biophysica Acta.doi:10.1016/j.physletb.2003.10.071
21. Suzuki Y, Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K.(2009). Are the effects of a-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? FEBS Letters.583:2157–2159.
22. Xiao Chen, Xiao Zhai, Jiazi Shi, Wen Wu Liu, Hengyi Tao, Xuejun Sun, Zhimin Kang.(2013). Lactulose Mediates Suppression of Dextran Sodium Sulfate-Induced Colon Inflammation by Increasing Hydrogen Production. Digestive Diseases and Sciences.DOI:10.1007/s10620-013-2563-7.